Press Releases
To stay up to date with our development, sign up for a subscription.
2020
2020-04-16 21:30
A shareholder wishing to participate at the meeting must be entered as shareholder in the share register kept by Euroclear Sweden AB on the record date Wednesday 13 May 2020, and must notify the company of their attendance no later than Wednesday 13 May...
2020-04-09 21:00
The nomination committee of Sedana Medical, which in relation to the annual general meeting 2020 consists of Karl Tobieson (chairman of the nomination committee and appointed by Linc AB), Thomas Eklund (chairman of the board), Sten Gibeck (shareholder...
2020-04-06 08:00
On March 30, Sedana Medical announced that the company is experiencing a sharp increase in demand as a result of the novel corona virus. However, sales during the last days of March turned out to be significantly higher than expected and the company now...
2020-03-30 08:00
The novel coronavirus mainly affects the lungs and for the most severely affected the consequence is lung failure (ARDS). This condition is very difficult to treat, but studies indicate that inhaled sedation with AnaConDa may be beneficial for these patients...
2020-03-20 15:20
The extraordinary situation with the spread of COVID-19, has led to an increased amount of inquiries to Sedana Medical from intensive care units around the world for information about the use of the AnaConDa. Travel restrictions and hospitals closed for...
2020-03-13 08:00
Sedana Medical´s mission is to improve patient outcomes through medical innovation. Sedana Medical Research Grant was established in 2019 to stimulate and support international research and increase awareness and knowledge in sedation of critically...
2020-03-05 07:00
Financial Summary October-December Financial Summary January-December Significant events during the period Significant events after the period CEO comments Based on our future scenario and our priorities, the fourth quarter is our strongest ever. We build...
2020-02-27 08:00
Sedana Medical is a pioneer in making volatile anaesthetics available to critically ill mechanically ventilated patients via the medical device AnaConDa. In the current situation, with the outbreak of the novel coronavirus (2019-nCoV), Sedana Medical...
2020-02-05 08:00
“We are proud that we can now start building market presence for inhaled sedation also in Belgium and the Netherlands. This is fully in line with our strategy to independently develop the inhaled sedation therapy in intensive care and the expansion...
2020-01-28 08:00
“The fact that we can now start selling on a new continent is gratifying, the approval in Mexico came sooner than both we and our distributor had expected, and we choose to see that as a sign of strength. However, work still remains to be done to...